RENOVION

renovion-logo

Renovion company is a pharmaceutical corporation with therapy for chronic inflammatory airway diseases. The company’s flagship pharmaceutical product, Arina-1, is still in pre-clinical stages.Renovation was formed in 2013 to leverage a pharmaceutical discovery at the University of North Carolina-Chapel Hill that reduces infection and addresses airway inflammation through the use of a novel therapy – Arina-1.

#SimilarOrganizations #People #Financial #Website #More

RENOVION

Industry:
Clinical Trials Health Care Pharmaceutical

Founded:
2013-01-01

Address:
Chapel Hill, North Carolina, United States

Country:
United States

Website Url:
http://www.renovion.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
14.36 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro ReCAPTCHA Wix


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

alphamab-oncology-logo

Alphamab Oncology

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

ocugen-logo

Ocugen

Ocugen is a clinical stage biopharmaceutical company.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.


Current Advisors List

jon-civitarese_image

Jon Civitarese Board Member @ RENOVION
Board_member
2020-06-18

not_available_image

Tom Barton Board Member @ RENOVION
Board_member
2020-06-18

Current Employees Featured

daniel-copeland_image

Daniel Copeland
Daniel Copeland Chief Executive Officer @ RENOVION
Chief Executive Officer
2015-10-01

carolyn-durham_image

Carolyn Durham
Carolyn Durham Chief Scientific Officer @ RENOVION
Chief Scientific Officer
2013-06-01

Founder


daniel-copeland_image

Daniel Copeland

Investors List

white-rock-capital_image

White Rock Capital

White Rock Capital investment in Series A - RENOVION

texas-halo-fund_image

Texas HALO Fund

Texas HALO Fund investment in Series A - RENOVION

Official Site Inspections

http://www.renovion.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.186
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "RENOVION"

RENUVION - Home

Renuvion is the #1 trusted body contouring technology by surgeons¹ and designed to treat loose skin directly at the source. Here’s how: The Renuvion wand is inserted under the skin, using a …See details»

Renovion | Restoring Lung Health, One Breath at a Time

Renovion is developing a new nebulizer therapy to treat lung mucus and improve lung function for patients of lung transplant, non-cystic fibrosis bronchiectasis (NCFBE), non-tuberculous mycobacteria-lung disease (NTM-LD), and …See details»

Renovion and the COPD Foundation Launch COPD and …

Renovion, a UNC Chapel Hill-supported biotechnology company, has developed ARINA-1, a novel nebulized therapy, to help patients who struggle with tenacious lung mucus and chronic …See details»

RENOVION - Crunchbase Company Profile & Funding

Renovion company is a pharmaceutical corporation with therapy for chronic inflammatory airway diseases. The company’s flagship pharmaceutical product, Arina-1, is still in the pre-clinical stages. Renovion was formed in 2013 to …See details»

Renovion and the COPD Foundation Launch COPD and …

Sep 21, 2021 · Renovion, a UNC Chapel Hill-supported biotechnology company, has developed ARINA-1, a novel nebulized therapy, to help patients who struggle with tenacious lung mucus …See details»

Renovion, Inc - LinkedIn

Renovion is a clinical-stage company dedicated to advancing therapies that restore lung health. Our product, ARINA·1, has been developed to change the lives of individuals with a lung transplant,...See details»

Renovion Company Profile - Office Locations, Competitors ... - Craft

Renovion (formerly known as The Repairion Group) is a company that develops therapies for chronic inflammatory airway diseases. It offers ARINA-1, a nebulized therapy for restoring lung …See details»

About - Renovion

Learn more about Renovion and the team behind ARINA-1, a new nebulizer therapy to treat lung mucus and improve lung function for patients of lung transplant, non-cystic fibrosis …See details»

Renovion Inc. - VentureRadar

Renovion is a clinical stage pharmaceutical company with a nebulized therapy that restores mucus clearance and reduces inflammation in the lungs. We are focused on developing …See details»

Renovion Provides Regulatory Update and Initiation of Clinical …

Apr 26, 2022 · Renovion is a clinical stage pharmaceutical company focused on developing ARINA-1, novel nebulized therapy delivered to the lungs to treat pulmonary diseases. ARINA …See details»

Renovion Company Profile 2024: Valuation, Funding

Developer of an advanced nebulized therapy designed to treat chronic inflammatory airway diseases.See details»

Renovion Inc. | North Carolina Biotech Center

Renovion is a clinical stage company developing therapies for chronic inflammatory lung diseases, including bronchiectasis, BOS in lung transplant and chronic bronchitis. Company …See details»

Renovion, Inc. Company Profile | Chapel Hill, NC | Competitors ...

Find company research, competitor information, contact details & financial data for Renovion, Inc. of Chapel Hill, NC. Get the latest business insights from Dun & Bradstreet.See details»

Carolyn Durham - Chief Scientific Officer at RENOVION - The Org

After a post-doc at UNC, she was the Scientific Advisor of Montague Capital, focusing on scientific strategy and collaboration. She has spearheaded the transition of ARINA-1 from 15 years of …See details»

News - Renovion

Stay up-to-date on news and information for the team at Renovion on developements and the FDA approval process for the ARINA-1 nebulized lung funtion therapy.See details»

Renovion Adds $350K to Lung Disease Drug Development Coffers

May 18, 2018 · Renovion, a Durham pharmaceutical company developing a therapy for chronic inflammatory airway diseases, has added $350,000 in private equity to the $1.8 million raised …See details»

Renovion Receives Notice of Study May Proceed Status for Lung ...

Aug 2, 2022 · Renovion is a clinical stage pharmaceutical company focused on developing ARINA-1, novel nebulized therapy delivered to the lungs to treat pulmonary diseases. ARINA …See details»

Renovion Announces Addition of Rich Mattingly to Board of …

Aug 26, 2020 · Renovion is a clinical stage pharmaceutical company with a nebulized therapy that restores mucus clearance and reduces inflammation in the lungs. The company is focused on …See details»

Renovion Announces Completion of $8.1 Million Financing

Jun 18, 2020 · Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced completion of a Series A …See details»

Renovion Announces Completion of $8.1 Million Financing Round …

Jun 18, 2020 · Renovion is a clinical stage pharmaceutical company with a nebulized therapy that restores mucus clearance and reduces inflammation in the lungs. The company is focused on …See details»

linkstock.net © 2022. All rights reserved